We are proud to present the genesis of Strainprint. Steph’s story is what defines us. With her story, and 1,000’s more like it we will continue to break the stigma & pave the way for the future of the cannabis industry. Have a look at Steph’s story, and if it resonates with you, consider sharing! […]
Dr. Caroline MacCallum, Dr. Danial Schecter & Dr. Dean Elterman Join Strainprint’s World-Class Medical Advisory Board TORONTO, April 17, 2018 /CNW/ – Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely […]
The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before. With the current state of cannabis working towards legalization across the globe, new channels of research are opening up across the board as an effort to rapidly catch up with a market ready to consume a product […]
Recently, our Community Manager and Patient Liaison, Ashleigh Brown, was featured on Women of Cannabiz http://www.womenofcannabiz.com/cannabis-entrepreneurs/ashleigh-brown
PRESS RELEASE: TORONTO, March 28, 2018 /CNW/ – Strainprint, the leader in cannabis data collection and strain efficacy reporting, is thrilled to announce the launch of Strainprint Analytics, a powerful web-based data platform for visually mining the world’s largest data set on strain efficacy and real-time patient use. On March 27, Strainprint gathered with key […]
National Post – Open Letter To ACMPR Medical Cannabis Patients Strainprint advocates for carving out and preserving our world class Medical Cannabis program. Read our letter posted in the National Post, share, and let Finance Canada know that taxing medical cannabis is wrong! #donttaxmedicine